Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
570.22
+1.17 (0.21%)
At close: May 9, 2025, 4:00 PM
570.22
0.00 (0.00%)
After-hours: May 9, 2025, 7:00 PM EDT
Chemed Market Cap
Chemed has a market cap or net worth of $8.31 billion as of May 9, 2025. Its market cap has decreased by -11.04% in one year.
Market Cap
8.31B
Enterprise Value
8.28B
1-Year Change
-11.04%
Ranking
Category
Stock Price
$570.22
Market Cap Chart
Since December 1, 1998, Chemed's market cap has increased from $321.30M to $8.31B, an increase of 2,486.55%. That is a compound annual growth rate of 13.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 8.34B | 5.09% |
Dec 31, 2024 | 7.94B | -9.88% |
Dec 29, 2023 | 8.81B | 16.04% |
Dec 30, 2022 | 7.59B | -6.81% |
Dec 31, 2021 | 8.14B | -4.14% |
Dec 31, 2020 | 8.50B | 20.82% |
Dec 31, 2019 | 7.03B | 55.03% |
Dec 31, 2018 | 4.54B | 16.90% |
Dec 29, 2017 | 3.88B | 49.09% |
Dec 30, 2016 | 2.60B | 2.93% |
Dec 31, 2015 | 2.53B | 40.67% |
Dec 31, 2014 | 1.80B | 33.04% |
Dec 31, 2013 | 1.35B | 2.12% |
Dec 31, 2012 | 1.32B | 29.95% |
Dec 30, 2011 | 1.02B | -29.66% |
Dec 31, 2010 | 1.45B | 33.77% |
Dec 31, 2009 | 1.08B | 21.63% |
Dec 31, 2008 | 889.70M | -33.46% |
Dec 31, 2007 | 1.34B | 37.62% |
Dec 29, 2006 | 971.50M | -24.07% |
Dec 30, 2005 | 1.28B | 52.89% |
Dec 31, 2004 | 836.80M | 83.67% |
Dec 31, 2003 | 455.60M | 31.56% |
Dec 31, 2002 | 346.30M | 3.90% |
Dec 31, 2001 | 333.30M | -0.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 695.75B |
Johnson & Johnson | 378.52B |
UnitedHealth Group | 353.17B |
AbbVie | 333.31B |
Novo Nordisk | 301.56B |
Abbott Laboratories | 233.14B |
Novartis AG | 220.92B |
AstraZeneca | 217.30B |